Council on Drugs. New and nonofficial drugs. JAMA. 1957;163(8):645–647. doi:10.1001/jama.1957.02970430035011
2.
WykoffCCFlynnHWJrRosenfeldPJ. Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics. Am J Ophthalmol. 2011;152:717–719.e712. doi:10.1016/j.ajo.2011.07.002
3.
GottardiW. Iodine and iodine compounds. In: BlockSS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia, PA: Lea & Febiger; 2001:159–184.
4.
BigliardiPLAlsagoffSALEl-KafrawiHYPyonJKWaCTCVillaMA. Povidone iodine in wound healing: a review of current concepts and practices. Int J Surg. 2017;44:260–268. doi:10.1016/j.ijsu.2017.06.073
5.
SpeakerMGMenikoffJA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769–1775. doi:10.1016/S0161-6420(91)32052-9
6.
MossJMSanisloSRTaCN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology. 2009;116(8):1498–1501. doi:10.1016/j.ophtha.2009.02.024
7.
BhavsarARStockdaleCRFerrisFL III, et al.Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol. 2012;130(6):809–810. doi:10.1001/archophthalmol.2012.227
8.
WuPCLiMChangSJ, et al.Risk of endophthalmitis after cataract surgery using different protocols for povidone-iodine preoperative disinfection. J Ocul Pharmacol Ther. 2006;22(1):54–61. doi:10.1089/jop.2006.22.54
9.
FriedmanDAMasonJO IIIEmondTMcGwinGJr. Povidone-iodine contact time and lid speculum use during intravitreal injection. Retina. 2013;33(5):975–981. doi:10.1097/IAE.0b013e3182877585
10.
BerkelmanRLHollandBWAndersonRL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15(4):635–639.
11.
HouangETGilmoreOJReidCShawEJ. Absence of bacterial resistance to povidone iodine. J Clin Pathol. 1976;29(8):752–755. doi:10.1136/jcp.29.8.752
12.
HsuJGerstenblithATGargSJVanderJF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157(3):514–518. doi:10.1016/j.ajo.2013.10.003
13.
JohaniKMaloneMJensenSO, et al.Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo. J Antimicrob Chemother. 2018;73(2):494–450. doi:10.1093/jac/dkx391
14.
TrostLWKivilcimMPeymanGAAydinEKaziAA. The effect of intravitreally injected povidone-iodine on Staphylococcus epidermidis in rabbit eyes. J Ocul Pharmacol Ther. 2007;23(1):70–77. doi:10.1089/jop.2006.0076
15.
Green-SimmsAEEkdawiNSBakriSJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011;151(2):329–332. doi:10.1016/j.ajo.2010.08.039
16.
AveryRLBakriSJBlumenkranzMS, et al.Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34(suppl 12):S1–S18. doi:10.1097/IAE.0000000000000399
17.
AllenHFMangiaracineAB. Bacterial endophthalmitis after cataract extraction. A study of 22 infections in 20,000 operations. Arch Ophthalmol. 1964;72:454–462. doi:10.1001/archopht.1964.00970020454003
18.
AllenHFMangiaracineAB. Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. Arch Ophthalmol. 1974;91(1):3–7. doi:10.1001/archopht.1974.03900060007002
19.
MeredithTAMcCannelCABarrC, et al.Postinjection endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2015;122(4):817–821. doi:10.1016/j.ophtha.2014.10.027
20.
ModjtahediBSvan ZylTPandyaHKLeonardRE IIEliottD. Endophthalmitis after intravitreal injections in patients with self-reported iodine allergy. Am J Ophthalmol. 2016;170:68–74. doi:10.1016/j.ajo.2016.07.010
21.
WykoffCCFlynnHWJrHanDP. Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use. Am J Ophthalmol. 2011;151(1):4–6. doi:10.1016/j.ajo.2010.08.044
22.
LeeHYStiegerMYawalkarNKakedaM. Cytokines and chemokines in irritant contact dermatitis. Mediators Inflamm. 2013;2013:916497. doi:10.1155/2013/916497
23.
DykesPJMarksR. An evaluation of the irritancy potential of povidone iodine solutions: comparison of subjective and objective assessment techniques. Clin Exp Dermatol. 1992;17(4):246-249. doi:10.1111/j.1365-2230.1992.tb02158.x
24.
ZamoraJL. Chemical and microbiological characteristics and toxicity of povidone iodine solutions. Am J Surg. 1986;151(3):400–406. doi:10.1016/0002-9610(86)90477-0
25.
OlsonRJBraga-MeleRChenSH, et al.Cataract in the adult eye preferred practice pattern. Ophthalmology. 2017;124(2):p1–P119. doi:10.1016/j.ophtha.2016.09.027
26.
StemMSRaoPLeeIJ, et al.Predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength. Ophthalmol Retina. 2019;4(1):3–7. doi:10.1016/j.oret.2018.09.013
27.
LachapelleJM. A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol. 2014;24(1):3–9. doi:10.1684/ejd.2013.2198
28.
AmschlerKFuchsTGeierJBuhlT. In search of a better patch test concentration for povidone-iodine. Contact Dermatitis. 2017;77(5):346–347. doi:10.1111/cod.12838
29.
LachapelleJM. Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Dermatitis. 2005;52(1):9–10. doi:10.1111/j.0105-1873.2005.00479.x
30.
WaranKDMunsickRA. Anaphylaxis from povidone-iodine. Lancet. 1995;345(8963):1506. doi:10.1016/s0140-6736(95)91063-8
31.
PedrosaCCostaHOliveiraGRomarizJPraçaF. Anaphylaxis to povidone in a child. Pediatr Allergy Immunol. 2005;16(4):361–362. doi:10.1111/j.1399-3038.2005.00272.x
32.
CastelainFGirardinPMoumaneLAubinFPelletierF. Anaphylactic reaction to povidone in a skin antiseptic. Contact Dermatitis. 2016;74(1):55–56. doi:10.1111/cod.12473
33.
Gonzalo GarijoMADurán QuintanaJABobadilla GonzálezPMáiquez AsueroP. Anaphylactic shock following povidone. Ann Pharmacother. 1996;30(1):37–40. doi:10.1177/106002809603000107
34.
AdachiAFukunagaAHayashiKKunisadaMHorikawaT. Anaphylaxis to polyvinylpyrrolidone after vaginal application of povidone-iodine. Contact Dermatitis. 2003;48(3):133–136. doi:10.1034/j.1600-0536.2003.00050.x
35.
WittenDMHirschFDHartmanGW. Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states. Am J Roentgenol Radium Ther Nucl Med. 1973;119(4):832–840. doi:10.2214/ajr.119.4.832
36.
ShehadiWH.Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med. 1975;124(1):145–152. doi:10.2214/ajr.124.1.145
37.
SchabelmanEWittingM. The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed. J Emerg Med. 2010;39(5):701–707. doi:10.1016/j.jemermed.2009.10.014
38.
Prieto-GarcíaATomásMPinedaR, et al.Skin test-positive immediate hypersensitivity reaction to iodinated contrast media: the role of controlled challenge testing. J Investig Allergol Clin Immunol. 2013;23(3):183–189.
39.
MacyEM. Current epidemiology and management of radiocontrast-associated acute- and delayed-onset hypersensitivity: a review of the literature. Perm J. 2018;22:17–72. doi:10.7812/TPP/17-072
40.
NooraniARabeyNWalshSRDaviesRJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone iodine in clean-contaminated surgery. Br J Surg. 2010;97(11):1614–1620. doi:10.1002/bjs.7214
41.
GreenKLivingstonVBowmanKHullDS. Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol. 1980;98(7):1273–1278. doi:10.1001/archopht.1980.01020040125020
42.
MacRaeSEdelhauserHBrownB. Corneal toxicity of presurgical skin antiseptics. Am J Ophthalmol. 1984;97(2):221–232. doi:10.1016/s0002-9394(14)76094-5
43.
CalnanCD. Contact dermatitis from drugs. Proc R Soc Med. 1962;55(1):39–42. doi:10.1177/003591576205500111
44.
MeraniRMcPhersonZELuckieAP, et al.Aqueous chlorhexidine for intravitreal injection antisepsis: a case series and review of the literature. Ophthalmology. 2016;123(12):2588–2594. doi:10.1016/j.ophtha.2016.08.022
